References
- Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77. https://doi.org/10.1038/386073a0
- Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, Romeo F, Mehta JL. 2014. LOX-1, oxidant stress, mtDNA damage, autophagy, and immune response in atherosclerosis. Can. J. Physiol. Pharmacol. 92: 524-530. https://doi.org/10.1139/cjpp-2013-0420
- Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P. 2013. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell. Mol. Life Sci. 70: 2859-2872. https://doi.org/10.1007/s00018-012-1194-z
- Murase T, Kume N, Kataoka H, Minami M, Sawamura T, Masaki T, et al. 2000. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler. Thromb. Vasc. Biol. 20: 715-720. https://doi.org/10.1161/01.ATV.20.3.715
- Shaw DJ, Seese R, Ponnambalam S, Ajjan R. 2014. The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology. Diab. Vasc. Dis. Res. 11: 410-418. https://doi.org/10.1177/1479164114547704
- Li D, Patel AR, Klibanov AL, Kramer CM, Ruiz M, Kang BY, et al. 2010. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ. Cardiovasc. Imaging 3: 464-472. https://doi.org/10.1161/CIRCIMAGING.109.896654
- Yamada T. 2011. Therapeutic monoclonal antibodies. Keio J. Med. 60: 37-46. https://doi.org/10.2302/kjm.60.37
- Andersen DC, Reilly DE. 2004. Production technologies for monoclonal antibodies and their fragments. Curr. Opin. Biotechnol. 15: 456-462. https://doi.org/10.1016/j.copbio.2004.08.002
- Tokunaga M, Mizukami M, Yamasaki K, Tokunaga H, Onishi H, Hanagata H, et al. 2013. Secretory production of single-chain antibody (scFv) in Brevibacillus choshinensis using novel fusion partner. Appl. Microbiol. Biotechnol. 97: 8569-8580. https://doi.org/10.1007/s00253-013-4695-2
- Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, Hamid M. 2012. scFv antibody: principles and clinical application. Clin. Dev. Immunol. 2012: 980250.
- Iwamoto S, Fujita Y, Kakino A, Yanagida K, Matsuda H, Yoshimoto R, et al. 2011. An alternative protein standard to measure activity of LOX-1 ligand containing apoB (LAB) - utilization of anti-LOX-1 single-chain antibody fused to apoB fragment. J. Atheroscler. Thromb. 18: 818-828. https://doi.org/10.5551/jat.9142
- Babaei A, Zarkesh-Esfahani SH, Gharagozloo M. 2011. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli. J. Microbiol. Biotechnol. 21: 529-535. https://doi.org/10.4014/jmb.1010.10022
- Shahryari F, Safarnejad MR, Shams-Bakhsh M, Schillberg S, Nolke G. 2013. Generation and expression in plants of a single-chain variable fragment antibody against the immunodominant membrane protein of Candidatus Phytoplasma aurantifolia. J. Microbiol. Biotechnol. 23: 1047-1054. https://doi.org/10.4014/jmb.1301.01054
- Groff D, Armstrong S, Rivers PJ, Zhang J, Yang J, Green E, et al. 2014. Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins. MAbs 6: 671-678. https://doi.org/10.4161/mabs.28172
- Liu A, Ye Y, Chen W, Wang X, Chen F. 2015. Expression of V(H)-linker-V(L) orientation-dependent single-chain Fv antibody fragment derived from hybridoma 2E6 against aflatoxin B1 in Escherichia coli. J. Ind. Microbiol. Biotechnol. 42: 255-262. https://doi.org/10.1007/s10295-014-1570-9
- Chen C, Snedecor B, Nishihara JC, Joly JC, McFarland N, Andersen DC, et al. 2004. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnol. Bioeng. 85: 463-474. https://doi.org/10.1002/bit.20014
- Mu T, Liang W, Ju Y, Wang Z, Wang Z, Roycik MD, et al. 2013. Efficient soluble expression of secreted matrix metalloproteinase 26 in Brevibacillus choshinensis. Protein Expr. Purif. 91: 125-133. https://doi.org/10.1016/j.pep.2013.07.012
- Choy CJ, Berkman CE. 2016. A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry. J. Enzyme Inhib. Med. Chem. 31: 1690-1693. https://doi.org/10.3109/14756366.2015.1132208
- Liu Y, Meng Z, Shi R, Zhan L, Hu W, Xiang H, et al. 2015. Effects of temperature and additives on the thermal stability of glucoamylase from Aspergillus niger. J. Microbiol. Biotechnol. 25: 33-43. https://doi.org/10.4014/jmb.1406.06045
- Gao YS, Su JT, Yan YB. 2010. Sequential events in the irreversible thermal denaturation of human brain-type creatine kinase by spectroscopic methods. Int. J. Mol. Sci. 11: 2584- 2596. https://doi.org/10.3390/ijms11072584
- Cheng YM, Lu MT, Yeh CM. 2015. Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensis. BMC Biotechnol. 15: 32. https://doi.org/10.1186/s12896-015-0149-5
- Onishi H, Mizukami M, Hanagata H, Tokunaga M, Arakawa T, Miyauchi A. 2013. Efficient production of anti-fluorescein and anti-lysozyme as single-chain anti-body fragments (scFv) by Brevibacillus expression system. Protein Expr. Purif. 91: 184-191. https://doi.org/10.1016/j.pep.2013.08.005
- Hanagata H, Mizukami M, Miyauchi A. 2014. Efficient expression of antibody fragments with the Brevibacillus expression system. Antibodies 3: 242-252. https://doi.org/10.3390/antib3020242
- D'Urzo N, Martinelli M, Nenci C, Brettoni C, Telford JL, Maione D. 2013. High-level intracellular expression of heterologous proteins in Brevibacillus choshinensis SP3 under the control of a xylose inducible promoter. Microb. Cell Fact. 12: 12. https://doi.org/10.1186/1475-2859-12-12
- Maehashi K, Matano M, Saito M, Udaka S. 2010. Extracellular production of riboflavin-binding protein, a potential bitter inhibitor, by Brevibacillus choshinensis. Protein Expr. Purif. 71: 85-90. https://doi.org/10.1016/j.pep.2009.12.016
- Zou C, Duan X, Wu J. 2016. Efficient extracellular expression of Bacillus deramificans pullulanase in Brevibacillus choshinensis. J. Ind. Microbiol. Biotechnol. 43: 495-504. https://doi.org/10.1007/s10295-015-1719-1
- Gaciarz A, Veijola J, Uchida Y, Saaranen MJ, Wang C, Horkko S, Ruddock LW. 2016. Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli. Microb. Cell Fact. 15: 22. https://doi.org/10.1186/s12934-016-0419-5
- Tsybovsky Y, Shubenok DV, Kravchuk ZI, Martsev SP. 2007. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain. Protein Eng. Des. Sel. 20: 481-490. https://doi.org/10.1093/protein/gzm034
- Baden EM, Owen BA, Peterson FC, Volkman BF, Ramirez- Alvarado M, Thompson JR. 2008. Altered dimer interface decreases stability in an amyloidogenic protein. J. Biol. Chem. 283: 15853-15860. https://doi.org/10.1074/jbc.M705347200
- Panchal J, Kotarek J, Marszal E, Topp EM. 2014. Analyzing subvisible particles in protein drug products: a comparison of dynamic light scattering (DLS) and resonant mass measurement (RMM). AAPS J. 16: 440-451. https://doi.org/10.1208/s12248-014-9579-6
- Jonasson P, Liljeqvist S, Nygren PA, Stahl S. 2002. Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol. Appl. Biochem. 35: 91-105. https://doi.org/10.1042/BA20010099
- Turoverov KK, Haitlina SY, Pinaev GP. 1976. Ultra-violet fluorescence of actin. Determination of native actin content in actin preparations. FEBS Lett. 62: 4-6. https://doi.org/10.1016/0014-5793(76)80003-8
Cited by
- Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides vol.2017, pp.None, 2017, https://doi.org/10.1155/2017/8946935
- Preparation and Antioxidant Activities In Vitro of a Designed Antioxidant Peptide from Pinctada fucata by Recombinant Escherichia coli vol.28, pp.1, 2017, https://doi.org/10.4014/jmb.1708.08032
- Production of recombinant beta-amylase ofBacillus aryabhattai vol.49, pp.1, 2019, https://doi.org/10.1080/10826068.2018.1536987
- Immunocontraceptive Effects in Male Rats Vaccinated with Gonadotropin-Releasing Hormone-I and -II Protein Complex vol.29, pp.4, 2019, https://doi.org/10.4014/jmb.1901.01067
- Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms vol.11, pp.None, 2017, https://doi.org/10.3389/fmicb.2020.01927
- Available strategies for improved expression of recombinant proteins in Brevibacillus expression system: a review vol.40, pp.7, 2017, https://doi.org/10.1080/07388551.2020.1805404
- Induction of immunocontraceptive effects in both male and female mice immunized with GnRH vaccine vol.7, pp.5, 2017, https://doi.org/10.1002/vms3.563